![PDF) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer PDF) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer](https://i1.rgstatic.net/publication/44650853_American_Society_of_Clinical_OncologyCollege_of_American_Pathologists_Guideline_Recommendations_for_Immunohistochemical_Testing_of_Estrogen_and_Progesterone_Receptors_in_Breast_Cancer/links/0912f509826debcda2000000/largepreview.png)
PDF) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology
Syapse - A study in the Journal of Clinical Oncology concludes increasing access to germline genetic testing could expand clinicians' ability to apply precision treatments and personalize risk assessment for breast cancer
![Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined. | Semantic Scholar Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b8dc2360d630f1b27a065153037c5510f2a8abac/2-Table1-1.png)
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined. | Semantic Scholar
![Paolo Tarantino on Twitter: "In June 2020, an issue of JCO was published, including the first data of T-DXd in HER2-low MBC & the first review on this entity (https://t.co/peW12yxzPp) 2 years Paolo Tarantino on Twitter: "In June 2020, an issue of JCO was published, including the first data of T-DXd in HER2-low MBC & the first review on this entity (https://t.co/peW12yxzPp) 2 years](https://pbs.twimg.com/media/FRXYbrzXsAABoT6.jpg:large)
Paolo Tarantino on Twitter: "In June 2020, an issue of JCO was published, including the first data of T-DXd in HER2-low MBC & the first review on this entity (https://t.co/peW12yxzPp) 2 years
![Network pharmacology to unveil the biological basis of gy ii in breast cancer treatment International Journal of Clinical Oncology & Cancer Therapy Network pharmacology to unveil the biological basis of gy ii in breast cancer treatment International Journal of Clinical Oncology & Cancer Therapy](https://www.sciforce.org/public/journals/46/journalThumbnail_en_US.png)
Network pharmacology to unveil the biological basis of gy ii in breast cancer treatment International Journal of Clinical Oncology & Cancer Therapy
![VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer | 2 Minute Medicine VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2022/05/2MM-VA-5.15.2022_1_EarlyBC_Capecitabine_Adjuvant-scaled.jpg)
VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer | 2 Minute Medicine
Scholarly Article or Book Chapter | Breast cancer subtypes and response to docetaxel in node-positive breast cancer: Use of an immunohistochemical definition in the BCIRG 001 trial | ID: x346d625j | Carolina Digital Repository
![Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients | European Journal of Clinical Medicine Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients | European Journal of Clinical Medicine](https://www.ej-clinicmed.org/public/journals/1/article_59_cover_en_US.jpg)
Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients | European Journal of Clinical Medicine
![Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/610b661a-5f0f-4b71-903c-92f8e709b086/gr1.jpg)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![IU School of Medicine research findings provide advances in treatment of triple negative breast cancer IU School of Medicine research findings provide advances in treatment of triple negative breast cancer](https://mc-42b990dd-5dae-4647-b81e-424724-cdn-endpoint.azureedge.net/-/media/news/2021/20211215_schneider.jpg?rev=5b7df42b4ad54073a2fb9e0395f230ea&h=300&w=449&la=en&hash=315F32876103D10F24508EF55BE93D2D)